Transplantation, AutologousCyclophosphamideHematopoietic Stem Cell TransplantationStem Cell TransplantationAntineoplastic Combined Chemotherapy ProtocolsCombined Modality TherapyPeripheral Blood Stem Cell TransplantationMelphalanMultiple MyelomaTreatment OutcomeTransplantation ConditioningTransplantation, HomologousDisease-Free SurvivalEtoposideRemission InductionSalvage TherapyDoxorubicinHodgkin DiseaseVincristineSurvival RateLymphoma, Non-HodgkinStem CellsSurvival AnalysisChemotherapy, AdjuvantCytarabineHematopoietic Stem Cell MobilizationRecurrenceCarmustineBone Marrow TransplantationMyeloablative AgonistsThiotepaAntineoplastic AgentsPrognosisGraft vs Host DiseaseAntineoplastic Agents, AlkylatingBone Marrow PurgingCisplatinWhole-Body IrradiationHematologic NeoplasmsAntibodies, Monoclonal, Murine-DerivedFollow-Up StudiesBusulfanRetrospective StudiesPrednisoneLymphoma, Mantle-CellGranulocyte Colony-Stimulating FactorDexamethasoneIfosfamideHematopoietic Stem CellsAmyloidosisBoronic AcidsPyrazinesTime FactorsInduction ChemotherapyGraft SurvivalLymphoma, FollicularAntigens, CD34CarboplatinDrug Administration ScheduleLymphoma, Large B-Cell, DiffuseBreast NeoplasmsThalidomideLymphomaLymphoma, T-Cell, PeripheralAutograftsLeukapheresisNeoplasm StagingLiver TransplantationNeoplasm Recurrence, LocalMethotrexatePodophyllotoxinNeoplasm, ResidualMaintenance ChemotherapyMesenchymal Stem Cell TransplantationLeukemia, Myeloid, AcuteProspective StudiesMitoxantroneAntibodies, MonoclonalBleomycinTransplantation ChimeraImmunosuppressive AgentsLymphoma, B-CellNeutropeniaTissue DonorsCord Blood Stem Cell TransplantationNeoplasms, Second PrimaryCell TransplantationMyelodysplastic SyndromesIdarubicinNeoplasmsNeoadjuvant TherapyClinical Trials as TopicFeasibility StudiesKaplan-Meier EstimateDose-Response Relationship, DrugKidney TransplantationBlood Transfusion, AutologousBlood Component RemovalEnteropathy-Associated T-Cell LymphomaLeukemia, Plasma Cell